Abstract
BackgroundTo validate and compare various MRI-based radiomics models to evaluate treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal cancer.MethodsA total of 80 patients with locally advanced rectal cancer (LARC) who underwent surgical resection after nCRT were enrolled retrospectively. Rectal MR images were scanned pre- and post-nCRT. The radiomics features were extracted from T2-weighted images, then reduced separately by least absolute shrinkage and selection operator (LASSO) and principal component analysis (PCA). Four classifiers of Logistic Regression, Random Forest (RF), Decision Tree and K-nearest neighbor (KNN) models were constructed to assess the tumor regression grade (TRG) and pathologic complete response (pCR), respectively. The diagnostic performances of models were determined with leave-one-out cross-validation by generating receiver operating characteristic curves and decision curve analysis.ResultsThree features related to the TRG and 11 features related to the pCR were obtained by LASSO. Top five principal components representing a cumulative contribution of 80% to overall features were selected by PCA. For TRG, the area under the curve (AUC) of RF model was 0.943 for LASSO and 0.930 for PCA, higher than other models (P < 0.05 for both). As for pCR, the AUCs of KNN for LASSO and PCA were 0.945 and 0.712, higher than other models (P < 0.05 for both). The DCA showed that LASSO algorithm was clinically superior to PCA.ConclusionMRI-based radiomics models demonstrated good performance for evaluating the treatment response of LARC after nCRT and LASSO algorithm yielded more clinical benefit.
Highlights
To validate and compare various magnetic resonance imaging (MRI)-based radiomics models to evaluate treatment response to neoadjuvant chemoradiotherapy of rectal cancer
tumor regression grade (TRG) classification or pathologic complete response (pCR) status determination can only be confirmed by postoperative pathology, and no reliable and accurate evaluation system has been developed for preoperative therapeutic response [6]
Radiomics features Totally 1409 radiomics features were obtained from rectal MRI pre- and post- neoadjuvant chemoradiotherapy (nCRT) each, indicating a total of 2818 radiomic features
Summary
To validate and compare various MRI-based radiomics models to evaluate treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal cancer. Radiomics shows multiple advantages in evaluating therapeutic response over traditional imaging analysis [7,8,9,10], thereby providing important details of tissue features [11,12,13,14,15,16,17,18,19]. To our knowledge which feature reduction and machine learning model can yield more clinically benefit remains unclear.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.